Ruzanna Papyan, Clinical Research Physician at Immune Oncology Research Institute, shared a post on LinkedIn:
“Save the Date!
We are thrilled to announce our next GNN Educational Session on Thursday, October 16, 2025, at 8:30 AM ET!
We’ll be joined by Dr. Michael D. Hogarty from the Children’s Hospital of Philadelphia, who will lead a fascinating session on: “What is DFMO, how does it work, and how can we better use it to treat neuroblastoma?”
Don’t miss this opportunity to learn from one of the leading experts in the field!
Date: October 16, 2025
Time: 8:30 AM ET.”
More from Ruzanna Papyan on OncoDaily.